Abstract
Initial monotherapy for Parkinson’s disease (PD) includes carbidopa/levodopa; however, treatment approaches vary with disease progression owing to fluctuations in symptom control and increasing disability. This study describes treatment patterns in newly treated patients with PD following carbidopa/levodopa initiation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
